Arthur Kuan is the founder of CG Oncology. CG Oncology has raised $200M in total funding. Latest round: IPO. Based in Irvine, California.
Arthur Kuan is the CEO of CG Oncology, a late-stage clinical biopharmaceutical company focused on developing a bladder-sparing therapeutic for bladder cancer. He became CEO in 2016 and has since led the company through multiple financing rounds and a successful IPO in January 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide